estr
Oestrogen hormones and drugs that mimic them.
- Drugs containing estr: 38
- Approved somewhere: 16
- With a US drug page: 18
- Stem
- estr
- Class
- Oestrogen hormones and drugs that mimic them
- Sub-stems
- -gestr-
- Most common targets
- ESR1 (10), PGR (8), ESR1, ESR2 (7), ESR2 (1), DNA (1), Glycosaminoglycans (1), AR (1)
Approved and clinical-stage drugs in ChEMBL whose names containing estr or one of its sub-stems, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Diethylstilbestrol | Approved | ESR1 | Estrogen receptor alpha agonist |
| Diethylstilbestrol diphosphate | Approved | ESR1, ESR2 | Estrogen receptor agonist |
| Estradiol valerate | Approved | ESR1 | Estrogen receptor alpha agonist |
| Estramustine phosphate | Approved | ESR2, DNA | Estrogen receptor beta modulator |
| Estrogens, conjugated | Approved | ESR1, ESR2 | Estrogen receptor agonist |
| Estrogens, conjugated synthetic a | Approved | ESR1, ESR2 | Estrogen receptor agonist |
| Polyestradiol phosphate | Approved | ESR1 | Estrogen receptor alpha agonist |
| Vestronidase alfa | Approved | Glycosaminoglycans | Glycosaminoglycans hydrolytic enzyme |
| Estramustine | Phase 3 | — | — |
| Estrone | Phase 3 | ESR1 | Estrogen receptor alpha agonist |
| Dienestrol | — | ESR1 | Estrogen receptor alpha agonist |
| Ethylestrenol | — | AR | Androgen Receptor agonist |
| Quinestrol | — | ESR1, ESR2 | Estrogen receptor agonist |
| Estradiol | Approved | ESR1 | Estrogen receptor alpha agonist |
| Estradiol acetate | Approved | ESR1 | Estrogen receptor alpha agonist |
| Estrogens, esterified | Approved | ESR1, ESR2 | Estrogen receptor agonist |
| Estrone sulfuric acid | Approved | ESR1 | Estrogen receptor alpha agonist |
| Fluoroestradiol | Approved | — | Diagnostic agent |
| Estriol | Phase 3 | ESR1, ESR2 | Estrogen receptor modulator |
| Estrogen | Phase 3 | — | — |
| Promestriene | Phase 3 | — | — |
| Debamestrocel | Phase 2 | — | — |
| Oleoylestrone | Phase 2 | — | — |
| Olestra | Phase 2 | — | — |
| Pangumestrocel | Phase 2 | — | — |
| Allylestrenol | — | ESR1, ESR2, PGR | Estrogen receptor agonist |
| Estradiol cypionate | — | ESR1 | Estrogen receptor alpha agonist |
| Hexestrol | — | — | — |
| Lynestrenol | — | — | — |
| Mestranol | — | ESR1 | Estrogen receptor alpha agonist |
| Levonorgestrel | Approved | PGR | Progesterone receptor agonist |
| Megestrol acetate | Approved | PGR | Progesterone receptor agonist |
| Norgestrel | Approved | PGR | Progesterone receptor agonist |
| Vepdegestrant | Phase 3 | — | — |
| Etonogestrel | Phase 2 | PGR | Progesterone receptor agonist |
| Desogestrel | Phase 3 | PGR | Progesterone receptor agonist |
| Nomegestrol acetate | Phase 3 | PGR | Progesterone receptor agonist |
| Norelgestromin | Phase 2 | PGR | Progesterone receptor agonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO